Variant Interpretation & Clinical Genomics Software Directory

Variant Interpretation & Clinical Genomics covers the software layer where called variants from NGS pipelines are annotated, classified under ACMG/AMP or oncology tiering frameworks, and linked to curated disease and therapeutic evidence for diagnostic sign-out. The work sits between secondary analysis and the issued clinical report, and it is shaped by tensions that do not apply elsewhere in Genomics & Omics Analysis: regulated turnaround times, evidence that shifts as literature accumulates, the need to defend each classification with cited sources, and integration constraints with LIMS, EHR, and accreditation workflows. Users are predominantly clinical and diagnostic professionals working alongside bioinformaticians who maintain the underlying pipelines.

Two patterns stand out across the category. Deployment is heavily weighted toward cloud and SaaS — around 80% — which reflects the operational cost of maintaining continuously updated variant knowledge bases that on-premise installations struggle to keep current. The compliance profile is also distinctive: roughly half the tools attest to HIPAA, while GxP and 21 CFR Part 11 coverage remains a minority position, suggesting most platforms are built for diagnostic laboratory use rather than regulated pharma workflows. Just over half incorporate AI or ML components, typically for variant prioritisation, literature mining, or evidence summarisation rather than autonomous classification.